Voluntary announcement - purchase of shares by the trustee for the purpose of the 2022 RSU scheme
Filed with HKEX · Stock code 6855 · · 2 pages · English
Summary by 6ix AI
The Trustee purchased existing shares on-market to satisfy RSUs upon vesting, with details provided about the number of shares and their consideration. The announcement also notes that the Trustee will not exercise voting rights for the shares held under the scheme.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Ascentage Pharma Group International on 6ix
Earlier from Ascentage Pharma Group International
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement - acquisition of shares by the chairman and executive director
- Interim report 2026
- Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
- CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
Later from Ascentage Pharma Group International
All Ascentage Pharma Group International news releasesFollow Ascentage Pharma Group International into a list and get an email when it puts out news.
Follow Ascentage Pharma Group International